GENE ONLINE|News &
Opinion
Blog

2022-01-17|

ARM 2022: Industry Briefs on Cell and Gene Therapies

by Sahana Shankar
Share To
One global network, the Alliance for Regenerative Medicine (ARM), represents 400 members from industry and academia in advocating for innovations and support of cell, gene, tissue-based advanced therapies. At the ARM’s virtual 2022 Cell & Gene State of the Industry Briefing, two experts highlighted the sector’s progress in 2021 and welcomed industry experts to share their views on the promising future of regenerative medicine in 2022 and 2023. The speakers are: 

It's free! Log in now to read

LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
North Star Review Board Launches Nonprofit Model for Institutional Oversight
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
106 Adults Receive Free Dementia Screenings at Atlanta Community Organizations
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
Boston College Chemist Receives $600,000 NSF Grant to Study Transition Metal Oxychlorides for Battery Storage
2026-08-10
Researchers Identify Related Viruses to Mitigate Koi Herpesvirus in Carp Populations
2026-08-10
Scroll to Top